Pathway analysis showed the top five most significant pathways involved were p53 signaling pathway, bladder cancer, chronic myeloid leukemia, small cell lung cancer and ErbB signaling pathway (Supplementary Figure 1B). This evidence concerns the gene EGFR and chronic myelogenous leukemia, BCR-ABL1 positive.